Drugs on TrumpRx will be listed from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer, which are the first five manufacturers to reach most favored nation pricing deals with the Trump ...

Under Trump administration deals to lower drug prices, pharmaceutical companies are offering some of their drugs at ...

While much of the biopharma industry has spent the past 12 months treading lightly around the Trump administration and the tumult it has wrought on U.S. medical research and regulation, Pfizer’s CEO ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Five weeks after telling investors to expect a revenue decline in 2026, Pfizer has found a quick funding fix, selling off its stake in GSK’s ViiV Healthcare. The New York powerhouse has agreed to ...